A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND#117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (CHL) in Children and Adolescents
General Information
Age Group
Pediatrics/Children
Status
Active
Protocol Number
AHOD1331
Offered At
Inova Children's Hospital
3300 Gallows Road
Falls Church, VA 22042
